Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",18959,155,1.15 [0.92-1.43],0.2116321899933169
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19936,207,1.14 [0.94-1.37],0.183080775544985
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19701,1430,1.08 [1.01-1.16],0.0340996157861964
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Candidiasis,19952,456,1.08 [0.95-1.22],0.2612485908296771
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19298,3524,1.08 [1.03-1.13],0.0013028141879853
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19264,3565,1.05 [1.01-1.10],0.0289213580500108
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19701,1187,1.10 [1.02-1.19],0.0173436413634222
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19862,110,1.13 [0.88-1.46],0.3347872536426292
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17596,1048,1.08 [0.99-1.17],0.0761727784900422
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,16953,1259,1.08 [1.00-1.16],0.0550683717684426
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,16605,275,1.13 [0.96-1.33],0.1455873993316697
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,13003,2262,1.05 [0.99-1.11],0.0839191557943856
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16551,401,1.17 [1.02-1.34],0.0213953131455848
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19918,1404,1.09 [1.02-1.18],0.0136971366810068
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Mycoses,20023,527,1.09 [0.97-1.23],0.1415102048150342
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,19282,1011,1.07 [0.99-1.17],0.0961654456859197
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,19964,1160,1.07 [0.99-1.15],0.1119348293125317
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18721,207,1.14 [0.95-1.38],0.1615202768949577
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,20072,52,0.99 [0.68-1.44],0.9706772724494862
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19814,1010,1.07 [0.98-1.16],0.1365096235445342
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19817,65,1.21 [0.86-1.69],0.267973157699055
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other viral diseases,20016,111,1.24 [0.96-1.59],0.0974568479872417
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",20001,96,1.25 [0.95-1.63],0.1108864088316383
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18660,389,1.15 [1.01-1.32],0.0400441800114949
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,18525,254,0.99 [0.83-1.17],0.9008027915196254
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18618,104,1.21 [0.93-1.57],0.1497221416922612
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,20057,47,0.96 [0.65-1.43],0.8508612168216334
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,20010,154,1.04 [0.84-1.30],0.6972426637357215
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Viral warts,19906,50,1.36 [0.93-1.97],0.1106127312760593
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19928,72,0.91 [0.66-1.26],0.5632202842889391
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign lipomatous neoplasm,19822,228,0.89 [0.75-1.07],0.2223104940665884
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19997,37,0.95 [0.61-1.49],0.8332189926004826
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19983,41,1.14 [0.75-1.73],0.5351395269916928
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,9505,72,0.84 [0.61-1.17],0.3083267802423987
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19671,1435,1.01 [0.94-1.08],0.8069746232073643
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm of meninges,20059,58,1.18 [0.83-1.68],0.3541275792490794
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19991,71,1.15 [0.84-1.58],0.384731647728037
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,20048,103,1.06 [0.81-1.38],0.6683908923548452
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm of ovary,10516,64,1.17 [0.84-1.62],0.358429700204712
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Ascending colon,20037,386,1.00 [0.87-1.15],0.9778313841208572
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Caecum,20049,330,0.99 [0.86-1.15],0.9317823289367664
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19946,74,0.93 [0.68-1.28],0.6499224769639118
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Descending colon,20035,223,1.05 [0.87-1.26],0.618413226860399
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Rectum,19991,353,0.97 [0.84-1.12],0.6573267074957949
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19935,600,1.03 [0.92-1.15],0.6322085661228678
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Transverse colon,20027,452,1.01 [0.89-1.14],0.9102392063862048
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Carcinoma in situ of breast,7924,45,0.82 [0.55-1.24],0.3540554792172657
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",7957,56,1.12 [0.78-1.60],0.5463313648444936
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",14386,64,1.19 [0.86-1.67],0.2965904880415048
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",14407,85,0.87 [0.65-1.17],0.3492779771650152
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",20019,110,0.92 [0.71-1.20],0.5426625857758972
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Haemangioma, any site",20020,107,0.92 [0.71-1.20],0.5408746552251646
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Leiomyoma of uterus,10278,147,1.08 [0.87-1.35],0.4757167040502473
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Lung cancer and mesothelioma,12794,434,1.04 [0.91-1.18],0.5764972998006292
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Lymphoid leukaemia,14387,65,1.29 [0.93-1.80],0.1224279371435207
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",14514,192,1.10 [0.90-1.33],0.3532290907238602
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",14583,261,0.95 [0.80-1.13],0.5547154926283426
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",8037,96,0.85 [0.64-1.13],0.2586650617619888
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",14417,95,1.04 [0.79-1.38],0.7557352125246686
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",14446,124,1.18 [0.93-1.50],0.1767301746429613
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",14433,111,0.98 [0.76-1.27],0.893497856816524
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",8023,82,0.86 [0.63-1.16],0.3169952553396766
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",14432,110,0.95 [0.73-1.23],0.6906736819623034
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7208,827,0.90 [0.81-0.99],0.0244150033688327
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",14438,116,0.85 [0.66-1.10],0.2236295456903854
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",14405,83,1.28 [0.96-1.72],0.0956593099548917
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,14445,123,1.15 [0.90-1.47],0.2574992773351928
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Melanocytic naevi,19945,161,1.22 [0.99-1.51],0.0652553405029438
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Melanocytic naevi of trunk,20048,67,1.53 [1.11-2.11],0.009437259633907
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Melanoma in situ,14369,100,1.17 [0.90-1.53],0.2481726195349849
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",14427,105,0.88 [0.68-1.16],0.3684705402062939
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",14496,174,1.02 [0.83-1.25],0.8603452193460428
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",14622,300,0.91 [0.78-1.06],0.2289062315595514
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",14436,114,1.12 [0.87-1.45],0.364521838978838
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Other benign neoplasms of skin,19924,147,0.93 [0.74-1.16],0.5319689481449181
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15590,1268,0.96 [0.89-1.03],0.2702308774098103
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15658,1336,0.97 [0.90-1.05],0.4345955869894979
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19812,327,1.08 [0.93-1.25],0.3352076425206294
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,18130,111,1.01 [0.78-1.31],0.9356559503276524
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19546,61,1.25 [0.89-1.76],0.1959327442076879
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19449,2939,1.07 [1.01-1.12],0.012122503858985
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18639,60,1.55 [1.10-2.17],0.0123328627348768
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19677,60,1.14 [0.80-1.62],0.4635499255166214
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19659,1640,1.05 [0.99-1.13],0.1264329330952705
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19657,1638,1.05 [0.98-1.12],0.1401253435461017
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,18118,99,0.91 [0.69-1.20],0.5030867628472655
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19769,1190,1.21 [1.12-1.31],1.444210540344857e-06
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19719,102,0.99 [0.75-1.30],0.9317203690271548
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,19542,57,0.92 [0.64-1.33],0.6530628054805175
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19556,71,1.12 [0.81-1.54],0.5001192602702513
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19913,296,0.85 [0.73-1.00],0.0539042631653942
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,19966,33,1.02 [0.64-1.63],0.9361513242343612
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19857,240,0.71 [0.59-0.85],0.0002034741235846
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18692,113,1.15 [0.89-1.48],0.2819735604477658
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,13578,335,1.08 [0.93-1.25],0.3373765688452941
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18787,85,1.12 [0.81-1.55],0.4795572261856059
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18795,93,1.16 [0.87-1.53],0.3166309628993447
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,13305,62,1.09 [0.77-1.53],0.638580755736674
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18691,43,1.04 [0.69-1.57],0.8439771896459994
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,18055,271,0.94 [0.80-1.11],0.4961696277776468
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",19420,760,0.94 [0.85-1.03],0.1944041139410456
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,19074,414,0.90 [0.78-1.03],0.114087089801935
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,18807,147,1.11 [0.89-1.38],0.3735521176540211
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19843,1195,1.12 [1.04-1.21],0.0039202329182497
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,17001,1166,1.13 [1.04-1.22],0.0025256898917803
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",13313,70,0.96 [0.69-1.33],0.8097726950741455
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",18148,85,1.10 [0.82-1.47],0.5289703970515828
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,13543,300,1.06 [0.91-1.24],0.433130270160419
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,13291,48,1.06 [0.72-1.57],0.7747433923002871
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,17166,3923,1.06 [1.01-1.11],0.0086788943951678
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,13472,229,1.01 [0.84-1.20],0.9470426890052264
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,13832,589,1.05 [0.94-1.17],0.4161309091761628
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,20024,309,1.07 [0.92-1.24],0.3976196001684192
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19839,124,0.95 [0.75-1.22],0.7001881848589548
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,13369,126,1.12 [0.88-1.42],0.3741601884370727
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",13312,69,1.24 [0.90-1.71],0.1961386721579019
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19534,1471,1.00 [0.93-1.07],0.9588147501600894
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,13557,314,1.16 [0.99-1.35],0.0606765023481183
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,13569,326,1.03 [0.88-1.20],0.7110723601187638
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",13977,734,1.09 [0.99-1.20],0.0937665143619304
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,13372,129,0.93 [0.73-1.19],0.5721948502238259
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19834,119,0.96 [0.75-1.22],0.7174048930822703
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,14003,760,1.06 [0.96-1.17],0.2252215118087596
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,13796,553,1.08 [0.96-1.21],0.2151946895577242
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,17845,61,1.10 [0.78-1.55],0.5958062942377578
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18732,5489,1.04 [1.00-1.08],0.0290021314597719
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,18113,50,0.99 [0.67-1.45],0.9400570362787402
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,18109,46,0.83 [0.56-1.24],0.3602182013154287
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19924,1594,0.97 [0.91-1.04],0.3729606841913326
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19922,1592,0.97 [0.91-1.04],0.4115154912550406
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,18118,55,1.01 [0.70-1.45],0.9625250893534112
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19768,977,1.04 [0.95-1.13],0.4282021318489095
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",15106,1863,1.06 [1.00-1.13],0.0638234321489404
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,20061,248,1.08 [0.91-1.29],0.3538723162029021
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,18757,97,0.98 [0.74-1.30],0.8992801682346756
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,18892,101,0.93 [0.71-1.22],0.6157621006614411
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,18934,143,1.14 [0.91-1.43],0.264588192422508
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",13408,165,1.11 [0.90-1.37],0.3082805961030961
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17685,155,1.09 [0.88-1.36],0.4105133392277328
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2133,83,1.19 [0.87-1.61],0.2794985751099829
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2267,249,1.03 [0.87-1.23],0.7163163275163418
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17598,68,1.32 [0.96-1.82],0.0909709594660488
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2100,51,0.81 [0.55-1.21],0.3142246044330206
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19371,1841,1.08 [1.01-1.15],0.0196987936777751
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,19172,512,0.88 [0.78-0.99],0.0312281263699866
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,18154,370,1.11 [0.97-1.28],0.127040702126751
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,14152,909,1.06 [0.97-1.16],0.2174888358607973
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19956,267,0.80 [0.68-0.95],0.010632697239938
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18818,228,0.85 [0.71-1.02],0.0760125797994541
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Angina pectoris,17386,1315,1.06 [0.98-1.14],0.1223114256829692
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Aortic aneurysm,18906,316,0.85 [0.73-0.99],0.0346609475579297
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18660,70,1.16 [0.84-1.59],0.3643128968655101
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18825,235,1.13 [0.95-1.35],0.1568603754194922
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,10234,2410,0.95 [0.90-1.00],0.0521627462754458
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,AV-block,15365,560,0.96 [0.86-1.08],0.5390979602610977
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",20000,475,0.98 [0.86-1.11],0.7468394104529456
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Cardiac arrest,8050,226,1.17 [0.98-1.39],0.0822774842313762
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Cardiomyopathy,14982,177,0.81 [0.66-1.00],0.0510199327851931
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",14894,89,0.90 [0.67-1.20],0.4676857315192847
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,20066,62,1.02 [0.72-1.45],0.8970509277947694
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Conduction disorders,16103,1298,1.00 [0.93-1.08],0.9933623106636532
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,18408,2359,1.01 [0.96-1.07],0.6247584080708011
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,16255,7726,1.00 [0.97-1.03],0.988586466018034
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18730,293,0.83 [0.71-0.98],0.024714333773804
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Endocarditis,14882,77,1.02 [0.75-1.39],0.9092187390598834
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19823,1395,1.07 [0.99-1.15],0.0739881788438267
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Hypertension,17314,6838,1.01 [0.98-1.05],0.4173708739726293
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Hypertension, essential",17319,6843,1.01 [0.98-1.05],0.4104454551323883
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Hypertension, portal",19927,85,0.76 [0.56-1.02],0.0698895351034419
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10720,244,1.18 [1.00-1.41],0.0554228210992237
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10605,129,1.18 [0.93-1.49],0.1714679178742289
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Hypotension,19916,1331,1.06 [0.99-1.15],0.0970954032274293
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,18983,126,0.80 [0.62-1.02],0.0671462659625926
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18561,2490,1.03 [0.97-1.08],0.3518450770304646
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19645,679,1.05 [0.95-1.16],0.366255534674373
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Left bundle-branch block,15235,430,1.05 [0.92-1.20],0.4746063815969228
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19508,905,1.04 [0.95-1.14],0.3650319440391094
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16850,779,1.08 [0.98-1.19],0.1263148359483189
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19958,165,1.30 [1.06-1.60],0.0115612839564376
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",20033,346,1.01 [0.87-1.17],0.8839099411450423
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Oesophageal varices,18495,58,0.83 [0.58-1.20],0.319119658184657
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other aneurysm,18676,86,1.16 [0.87-1.55],0.3038396271862184
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other arrhythmias,15304,499,1.05 [0.93-1.18],0.4603201679734322
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18703,113,1.19 [0.93-1.53],0.1633103797734217
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18861,271,1.07 [0.91-1.26],0.4390055936178078
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,14993,188,1.11 [0.91-1.36],0.2860890648159827
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other disorders of veins,18527,90,1.20 [0.91-1.60],0.2001727021221892
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,18476,39,1.04 [0.68-1.61],0.8460508137436902
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,18348,73,1.02 [0.74-1.40],0.921896537842464
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18581,144,1.03 [0.82-1.30],0.7803506589366122
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,16009,1204,0.99 [0.92-1.07],0.8337821939633467
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18636,51,0.96 [0.65-1.40],0.8171461108452712
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,19199,609,1.03 [0.92-1.14],0.6381132933269873
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19412,467,1.11 [0.98-1.26],0.0968110589101446
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",19092,817,1.04 [0.95-1.15],0.3757185948600587
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,8174,350,0.98 [0.85-1.14],0.816013446061439
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Peripheral artery disease,19051,492,1.08 [0.96-1.22],0.213484936717508
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18802,365,0.83 [0.72-0.96],0.0109547324092548
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19456,511,0.97 [0.86-1.09],0.572665460029169
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19981,810,1.03 [0.93-1.13],0.5902913942147601
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Right bundle-branch block,15241,436,1.02 [0.90-1.16],0.7469146305531573
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19407,462,1.12 [0.99-1.27],0.083338127092199
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,18492,217,0.93 [0.77-1.12],0.4459454518394273
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19629,772,1.02 [0.92-1.12],0.7178974922389266
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19617,805,1.02 [0.93-1.12],0.6552407560698592
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,18956,51,0.93 [0.64-1.36],0.7070679009425096
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18674,84,0.81 [0.60-1.10],0.1773443744576983
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Transient ischemic attack,19235,269,1.12 [0.95-1.32],0.1791555189281045
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18882,279,1.06 [0.90-1.24],0.4973950004026701
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Varicose veins,18876,439,1.04 [0.92-1.19],0.5183481330595292
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18605,98,0.78 [0.59-1.03],0.0826690335257099
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19831,807,0.91 [0.83-1.01],0.0676220078827638
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",20001,285,1.13 [0.96-1.32],0.1364830109127052
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",17255,1189,1.06 [0.98-1.14],0.1698328488639383
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Any mental disorder,19626,3560,1.04 [1.00-1.09],0.0648769258255316
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19976,335,1.07 [0.93-1.24],0.347428987138826
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",17282,1216,1.13 [1.05-1.22],0.0014803029709407
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",16129,63,0.97 [0.69-1.37],0.8490870209909318
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Smoking dependency,19633,994,1.10 [1.01-1.20],0.0337821585326453
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",17296,1230,1.08 [1.00-1.17],0.0445602703969288
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Vascular dementia,19353,200,0.87 [0.72-1.06],0.1716996518432448
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Alzheimer disease,20069,509,0.91 [0.81-1.03],0.1384530535096758
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",12527,96,1.01 [0.76-1.33],0.9501162560830216
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Bell's palsy,18501,72,1.01 [0.73-1.39],0.9569469938130264
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18852,423,1.08 [0.95-1.23],0.2454273401224442
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Cerebral cysts,19696,206,1.09 [0.90-1.31],0.3834933342432124
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,20006,328,0.89 [0.76-1.03],0.1207809223735363
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,19367,73,1.10 [0.80-1.51],0.5701984958343498
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,20053,62,0.86 [0.61-1.22],0.3951740587473323
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19557,67,1.30 [0.94-1.81],0.1112286495951751
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Epilepsy,18811,250,0.92 [0.77-1.09],0.3281617611832996
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19686,1125,1.04 [0.96-1.12],0.3769688563130327
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,20020,544,0.95 [0.85-1.07],0.4048375862757564
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19507,2876,0.98 [0.93-1.03],0.4080383367504643
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Generalized epilepsy,19761,45,1.43 [0.97-2.11],0.0746335096960085
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Hemiplegia,19946,268,0.98 [0.83-1.16],0.8411707057755251
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Hydrocephalus,19551,61,1.00 [0.71-1.41],0.999015619332568
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,20057,59,1.13 [0.80-1.60],0.4798158975580044
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,18492,63,0.80 [0.57-1.13],0.2077302583160103
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,18493,64,0.98 [0.69-1.37],0.8862094037682313
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Memory loss,19135,132,1.04 [0.82-1.31],0.7649347807882794
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Migraine,18795,234,1.05 [0.88-1.25],0.5757761130737492
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",20029,214,1.05 [0.87-1.26],0.6063247867065265
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Motor neuron disease,12617,164,1.04 [0.84-1.29],0.7037195965354741
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19958,52,1.06 [0.73-1.53],0.7647783677773334
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19462,1033,1.04 [0.96-1.13],0.3567017067184507
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Neurological diseases,18804,3549,1.01 [0.97-1.06],0.5595332184789948
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,19539,245,0.97 [0.81-1.15],0.7141934673984089
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18768,339,1.13 [0.98-1.31],0.0967098984654092
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",20000,286,1.14 [0.98-1.34],0.0961725709680819
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,15237,816,0.97 [0.88-1.07],0.5420481122321784
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19560,70,0.99 [0.71-1.37],0.9329844599223108
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19623,133,0.92 [0.73-1.16],0.4717525584207124
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19655,179,0.98 [0.80-1.20],0.8716785008002531
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other facial nerve disorders,18508,79,0.96 [0.71-1.31],0.8110474213183332
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other headache syndromes,18608,47,1.06 [0.72-1.57],0.7713179896845723
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other neurological diseases,19975,485,1.08 [0.95-1.22],0.2424459586812116
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other sleep disorders,18985,424,1.05 [0.92-1.20],0.4699441842010122
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Parkinson's disease,20038,346,0.94 [0.81-1.09],0.3939751707162526
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19530,40,1.16 [0.76-1.77],0.497535673295405
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Restless leg syndrome,20068,77,0.93 [0.68-1.26],0.637130855662294
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Sleep apnoea,19882,366,1.04 [0.90-1.20],0.576173345411138
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19765,51,1.06 [0.73-1.55],0.7482773951458136
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,20057,185,0.99 [0.81-1.21],0.925365934045439
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,18491,62,1.00 [0.71-1.41],0.9952066748980034
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,20069,514,0.91 [0.81-1.03],0.1216762518783182
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),19297,194,0.86 [0.71-1.05],0.1490023845825222
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,19523,131,0.90 [0.71-1.14],0.3727072009854281
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19694,491,0.96 [0.85-1.08],0.4757848358964196
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19864,220,0.99 [0.82-1.19],0.8829323877583498
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,19011,57,0.99 [0.69-1.42],0.977141625807338
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,18989,35,1.79 [1.15-2.79],0.009561693102349
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",19967,62,1.24 [0.88-1.74],0.2172620474772795
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19799,198,0.98 [0.81-1.19],0.8674551119407503
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2104,54,0.78 [0.53-1.15],0.2119127208650414
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2581,94,1.12 [0.84-1.50],0.434646162528054
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,19483,91,1.26 [0.95-1.66],0.1073686534550334
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19833,1218,1.07 [0.99-1.15],0.0896742428091266
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19710,756,1.02 [0.92-1.12],0.7075048183086508
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,19212,258,1.12 [0.95-1.33],0.1690680671530415
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",20013,810,0.98 [0.89-1.08],0.6612325915372862
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,20063,67,1.48 [1.07-2.04],0.017051652945112
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19959,756,0.97 [0.88-1.07],0.5531005799345259
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",20035,434,1.02 [0.89-1.16],0.7975403031840238
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,19966,193,1.10 [0.91-1.33],0.3329038840718063
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,19043,89,1.18 [0.89-1.58],0.2549540625543519
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,19042,88,1.05 [0.79-1.40],0.7436054140533117
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,19020,66,1.09 [0.78-1.52],0.6155872273428746
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19953,859,1.00 [0.91-1.09],0.929818261578892
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,19329,235,0.90 [0.75-1.08],0.247830478629331
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,19263,60,0.82 [0.57-1.17],0.267090686584344
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19711,110,0.86 [0.66-1.11],0.2389690752245558
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19936,335,1.05 [0.91-1.21],0.5229525941173121
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,19387,184,0.98 [0.80-1.20],0.8540919004689329
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19891,118,1.03 [0.80-1.32],0.818244410149656
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19654,560,1.02 [0.91-1.15],0.7030903869276599
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,19532,140,0.91 [0.72-1.15],0.4335584016849211
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17973,2786,1.04 [0.99-1.10],0.1131538430579856
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19902,301,1.02 [0.87-1.19],0.8283111393042294
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,20053,163,1.11 [0.90-1.37],0.3439361814979548
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19418,464,0.97 [0.86-1.10],0.6421882629456732
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19682,81,0.84 [0.62-1.14],0.2737008457042431
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,20055,59,1.51 [1.07-2.12],0.0180098739282857
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,19062,108,0.81 [0.63-1.06],0.1281736307327226
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19107,153,0.76 [0.61-0.95],0.0157728360038761
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,18757,142,1.21 [0.97-1.51],0.0974771489221929
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,19251,48,0.84 [0.57-1.26],0.4015616775914119
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18680,65,0.82 [0.58-1.15],0.2445003740806253
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,19195,101,0.91 [0.70-1.19],0.4945320040865417
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",19338,244,1.07 [0.90-1.26],0.4693429719592481
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,19085,131,1.01 [0.79-1.28],0.9534307699865292
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,18695,80,1.16 [0.86-1.57],0.3336932422308128
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,18723,108,1.11 [0.86-1.44],0.4270731494237672
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17511,2324,1.01 [0.96-1.07],0.669535688409131
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,19036,82,1.18 [0.88-1.59],0.268791552763128
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19824,432,1.00 [0.88-1.14],0.988177789152652
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,19460,68,1.05 [0.76-1.46],0.7552086542346059
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19559,167,1.07 [0.87-1.32],0.5049413949107796
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19867,99,0.92 [0.70-1.21],0.5309517964641874
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,20034,121,1.02 [0.80-1.31],0.8523446578918759
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19955,101,1.32 [1.02-1.72],0.037662112203595
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19828,60,0.91 [0.64-1.29],0.5810046644270976
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,19829,61,1.02 [0.72-1.44],0.919112603288731
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,19974,1021,1.07 [0.99-1.17],0.1006581696599249
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19723,770,1.10 [1.00-1.21],0.0525919242995806
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,19082,129,0.79 [0.62-1.01],0.0563582104735456
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,19031,78,1.15 [0.85-1.55],0.3691355218433255
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Acute pharyngitis,19903,53,1.03 [0.71-1.50],0.8699211286110429
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,20002,152,1.00 [0.80-1.24],0.9916750047974048
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19900,50,0.88 [0.60-1.29],0.5075528966282905
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,All influenza,17814,129,1.16 [0.91-1.46],0.2295132275427918
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),17811,126,1.17 [0.92-1.49],0.1923242984308454
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Allergic asthma (mode),12445,85,1.44 [1.09-1.92],0.0114626148954775
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Allergic rhinitis,19982,203,0.99 [0.82-1.20],0.9321544845342484
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13542,1506,1.11 [1.03-1.19],0.0041238220122636
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13847,1487,1.10 [1.03-1.18],0.0064676663282342
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19624,152,1.21 [0.98-1.51],0.0802964666226836
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",17771,86,1.27 [0.95-1.69],0.1081850049216127
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Bronchiectasis,16809,442,1.21 [1.07-1.37],0.0030893008652618
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",16430,63,1.45 [1.04-2.01],0.027786861603988
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19097,2730,1.09 [1.03-1.15],0.0010687761308399
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",19011,68,0.94 [0.68-1.32],0.7356247602691186
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Chronic sinusitis,19059,116,0.99 [0.77-1.27],0.9072047328203202
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19819,1387,1.10 [1.02-1.18],0.0123522183300873
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Deviated nasal septum,19014,71,1.01 [0.74-1.40],0.9362832257194644
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18205,5230,1.07 [1.03-1.11],0.0002780299361862
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",19242,299,1.12 [0.96-1.31],0.1592400544329829
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Early onset COPD,18533,101,1.11 [0.85-1.44],0.4525402029410342
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Emphysema,16747,380,1.18 [1.03-1.36],0.0160421299469245
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18924,407,1.09 [0.95-1.24],0.2165007186909077
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19841,2156,1.08 [1.02-1.15],0.0066127446032206
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Interstitial lung disease,18960,443,1.12 [0.99-1.27],0.0759407927957112
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Later onset COPD,19609,1286,1.10 [1.02-1.18],0.0172319641743359
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,20053,391,1.07 [0.93-1.23],0.3463639780624816
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Nasal polyp,19030,87,0.96 [0.71-1.29],0.777301042797744
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19824,1079,1.08 [1.00-1.18],0.0566860720631151
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other diseases of pleura,19817,2281,1.07 [1.01-1.13],0.0223943693751703
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19599,656,1.06 [0.96-1.18],0.2481883741105689
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other pleural conditions,17591,55,0.82 [0.57-1.19],0.3070722118400264
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19953,522,1.11 [0.98-1.24],0.0959423693434335
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19952,1463,1.11 [1.04-1.19],0.0030818178779041
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pleural effusion,18668,1132,1.07 [0.99-1.16],0.1031647525841544
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pleural plaque,17760,224,1.08 [0.91-1.30],0.3802882336563479
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19599,1914,1.09 [1.03-1.16],0.0057868074794638
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19954,292,1.08 [0.92-1.26],0.3617813725614707
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pneumothorax,17689,153,0.87 [0.70-1.09],0.2189765603199268
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pollen allergy,20060,170,1.05 [0.85-1.29],0.677141790050627
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pulmonary oedema,19508,77,0.90 [0.66-1.23],0.5080597293031532
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Respiratory insufficiency,12421,61,1.64 [1.19-2.27],0.0025272828894475
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19808,1063,1.08 [1.00-1.18],0.0628788458436928
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,19147,204,1.00 [0.83-1.21],0.985573364323332
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Viral pneumonia,17933,248,1.02 [0.86-1.22],0.7984370909874084
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19635,198,0.97 [0.80-1.18],0.7634665002177139
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6481,104,1.20 [0.92-1.56],0.1787615259079609
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12827,49,1.14 [0.78-1.68],0.496405290311837
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute appendicitis,19966,111,1.10 [0.85-1.41],0.4790839681184534
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute gastritis,14037,85,1.19 [0.90-1.59],0.2279772211176793
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute pancreatitis,18341,168,1.10 [0.89-1.35],0.3843932974410088
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute peritonitis,19658,93,1.23 [0.93-1.62],0.1403646448144124
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Alcoholic liver disease,19231,51,0.72 [0.48-1.06],0.0947663627107654
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Barrett oesophagus,14380,428,0.99 [0.87-1.13],0.8655979738412666
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",18297,124,1.17 [0.92-1.48],0.2136052333209591
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19713,124,1.16 [0.91-1.47],0.2420887462307838
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Cholecystitis,18358,185,0.97 [0.79-1.18],0.7653538906516495
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Cholelithiasis,19071,898,1.11 [1.01-1.21],0.0261259508168955
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Chronic gastritis,14248,296,1.01 [0.87-1.18],0.8796460055308714
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Chronic pancreatitis,18220,47,0.62 [0.42-0.94],0.0234236379429591
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19950,108,0.81 [0.62-1.06],0.1332520742583299
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Coeliac disease,18590,105,1.11 [0.85-1.43],0.4480574093788667
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Collagenous colitis,18567,88,0.90 [0.67-1.20],0.4755843857169967
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19965,143,1.10 [0.88-1.38],0.3979201930476029
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Constipation,19824,1768,1.00 [0.94-1.07],0.8955757664655472
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Crohn disease,18548,69,1.20 [0.87-1.66],0.2577103731424832
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19767,53,1.17 [0.81-1.69],0.4106992024859736
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18542,63,1.43 [1.03-2.00],0.0333838628961218
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Dental caries,19532,159,1.03 [0.83-1.28],0.7708481578948039
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,17387,2196,1.01 [0.95-1.07],0.7117490119889135
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of appendix,19992,137,1.08 [0.86-1.36],0.4857210254835709
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of liver,19972,792,0.95 [0.86-1.05],0.2966386428749191
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",17894,3942,1.03 [0.99-1.08],0.1659454407544633
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19777,404,0.95 [0.83-1.08],0.4229626625285505
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19995,430,1.07 [0.94-1.22],0.2846317784648546
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19454,81,0.87 [0.64-1.18],0.3638748302376737
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of salivary glands,19345,47,0.93 [0.63-1.39],0.7333735941208459
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19792,1307,1.00 [0.93-1.08],0.9875322040816412
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of tongue,19355,80,1.15 [0.85-1.55],0.3610928184271174
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19479,1306,1.09 [1.02-1.18],0.0173756288208659
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,16047,3269,1.02 [0.97-1.07],0.4479150085927829
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Duodenal ulcer,14155,203,1.06 [0.88-1.28],0.562446564944661
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19980,163,1.07 [0.87-1.33],0.5177868978857947
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,20041,20,1.15 [0.63-2.09],0.6456277857789341
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,19307,127,0.85 [0.66-1.08],0.1830997023481717
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12873,95,1.34 [1.02-1.75],0.0364592670858923
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Functional dyspepsia,14435,483,1.13 [1.00-1.27],0.0518276788399358
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastric ulcer,14315,363,1.07 [0.93-1.23],0.3534959978171041
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,16238,2286,1.03 [0.97-1.09],0.3774129499624894
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,14498,546,1.06 [0.95-1.19],0.2891988968480851
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14577,7107,1.02 [0.99-1.06],0.1428916700122918
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,GI-bleeding,19562,1077,0.99 [0.91-1.07],0.7859291243025923
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,19418,45,0.78 [0.52-1.18],0.2449048339746369
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,13630,1019,1.01 [0.92-1.10],0.8849547269298673
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",19239,59,0.73 [0.51-1.05],0.0887195384041972
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Hernia,18306,3115,1.02 [0.97-1.07],0.3765070819151843
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Impacted teeth,20043,19,1.26 [0.68-2.32],0.4629555782233521
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Impaction of intestines,12843,65,0.88 [0.62-1.23],0.451253382682042
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Inguinal hernia,16125,934,1.04 [0.95-1.14],0.3737945411708889
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",15292,101,1.06 [0.81-1.40],0.6620234635829897
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,12876,98,0.85 [0.64-1.12],0.2493346692352361
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18608,123,1.06 [0.83-1.35],0.6459923471481741
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,13214,436,1.05 [0.93-1.20],0.4306738759593569
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,20048,281,0.99 [0.84-1.17],0.942498456693281
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,19148,669,1.10 [0.99-1.22],0.0677263950471575
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19414,935,1.07 [0.98-1.17],0.125719924627399
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Oesophageal obstruction,14138,186,0.90 [0.74-1.10],0.2939173325381642
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Oesophagitis,14559,607,1.03 [0.92-1.15],0.6115884892888054
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,20018,119,1.18 [0.92-1.50],0.186551784664034
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,15262,71,1.10 [0.79-1.51],0.5725118261175033
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,13959,1181,1.05 [0.97-1.14],0.1852796209451133
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18477,304,1.06 [0.91-1.24],0.4427063581077521
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,18298,125,1.15 [0.90-1.46],0.2595550947039371
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of intestine,14449,1671,1.01 [0.94-1.08],0.8571564212211146
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of intestines,18078,5300,1.00 [0.96-1.04],0.9699591343168366
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19326,187,1.15 [0.94-1.40],0.1654573960048612
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of liver,19833,653,0.92 [0.83-1.03],0.1427330369908439
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,14610,658,0.99 [0.89-1.10],0.8547760066281854
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of pancreas,18353,180,0.96 [0.79-1.18],0.7144559992830792
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19930,365,1.05 [0.91-1.21],0.5169862492406421
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,14890,938,1.02 [0.93-1.11],0.7359943984197275
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19574,1089,0.98 [0.91-1.07],0.7087460577769558
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19522,149,0.86 [0.69-1.08],0.2024158492213529
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14583,1805,1.00 [0.94-1.06],0.97004007561399
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15813,1861,0.99 [0.93-1.05],0.711746082489567
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,19278,98,0.95 [0.72-1.25],0.7154440433195403
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19308,829,1.06 [0.97-1.17],0.196422128939127
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",13153,375,0.92 [0.80-1.06],0.258773850808298
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,20038,24,1.38 [0.80-2.36],0.2447978158354656
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,13302,524,0.90 [0.80-1.01],0.083846897432749
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18626,141,1.06 [0.85-1.33],0.6090669931049137
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Recurring oral aphthae,20057,45,0.86 [0.57-1.30],0.473522664325646
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,19367,86,1.15 [0.86-1.53],0.3498269226291136
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Toxic colitis,18552,73,1.08 [0.79-1.48],0.6380704351411581
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,14249,297,1.06 [0.91-1.24],0.4513724241516491
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Ulcerative colitis,18620,141,1.01 [0.81-1.27],0.899944067273453
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18593,114,0.98 [0.76-1.26],0.8907216323616497
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Umbilical hernia,15414,223,0.93 [0.77-1.11],0.4151979176184063
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,12986,208,0.83 [0.69-1.01],0.0570301818455058
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Ventral hernia,15425,234,1.11 [0.93-1.33],0.2280740790873242
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Volvulus,12854,76,0.80 [0.59-1.10],0.1649628605676115
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,19980,355,1.04 [0.90-1.20],0.5639979042427067
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19757,62,1.22 [0.87-1.71],0.2421316032083869
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,17908,143,1.03 [0.83-1.29],0.7802800172003832
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19533,711,1.06 [0.96-1.18],0.2314915500686822
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18943,121,1.03 [0.80-1.31],0.8369626309556077
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,18270,505,0.98 [0.87-1.11],0.7463317835866635
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19769,267,1.04 [0.88-1.22],0.6773048114539892
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19974,472,0.98 [0.87-1.11],0.7966611698924301
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,19545,43,0.91 [0.60-1.37],0.6405611255007964
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18690,3187,1.00 [0.96-1.05],0.8423850527466088
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19693,371,0.97 [0.85-1.12],0.7189614524017379
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19580,258,0.97 [0.82-1.15],0.7509675788921135
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19740,918,1.02 [0.94-1.12],0.6081702465388652
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",20052,52,0.86 [0.59-1.26],0.4403795445420786
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,17822,57,0.91 [0.64-1.31],0.6243407699937487
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19375,53,0.88 [0.61-1.28],0.5114709697865403
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19757,255,1.02 [0.86-1.21],0.8339735354291821
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,18282,517,0.98 [0.87-1.11],0.7603056928425044
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,17845,80,0.93 [0.68-1.26],0.625197927445502
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,19996,72,0.83 [0.60-1.14],0.2490700113598584
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,19006,184,1.09 [0.89-1.33],0.4087642280091317
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19890,195,1.06 [0.87-1.28],0.5766843968783755
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19578,76,0.91 [0.67-1.25],0.5609591960819111
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,17828,63,1.03 [0.74-1.45],0.8451279544342424
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,19542,1777,1.00 [0.94-1.07],0.9688205542768638
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",18320,555,0.96 [0.86-1.08],0.515151313501061
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,17848,83,0.89 [0.66-1.19],0.4259818404934106
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19991,296,1.07 [0.92-1.25],0.3834107493139519
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19568,66,1.01 [0.72-1.41],0.9702529734668998
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19938,243,1.11 [0.94-1.32],0.2307524123496608
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,20008,383,1.02 [0.89-1.17],0.7940643045449374
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17872,107,0.99 [0.77-1.29],0.9605704148031188
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,18052,287,0.82 [0.70-0.97],0.017909694724523
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19996,371,1.02 [0.88-1.17],0.8190081857631218
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",18036,271,1.21 [1.02-1.42],0.0249022947072636
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,20045,121,1.03 [0.80-1.32],0.8200939697772771
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,16746,68,0.67 [0.48-0.94],0.0219596584735182
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17699,5533,1.04 [1.01-1.08],0.0247880004941013
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16480,4314,1.03 [0.99-1.08],0.1060798577673427
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,16723,45,0.89 [0.59-1.33],0.5602766142902109
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16723,119,1.12 [0.87-1.43],0.3764721500382872
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16765,161,0.95 [0.77-1.18],0.6370315650697511
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19848,52,0.84 [0.57-1.23],0.3642523552050288
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",16728,124,1.08 [0.85-1.37],0.5389475272845472
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,13448,1282,1.03 [0.95-1.11],0.4758891855779904
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19879,215,1.01 [0.84-1.21],0.9214382739679524
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,17087,483,1.10 [0.97-1.24],0.1338971632312343
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16253,6923,1.04 [1.00-1.07],0.0347743067729163
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,17918,106,0.91 [0.70-1.19],0.5086009758990719
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,16830,152,1.11 [0.89-1.38],0.3514408448501933
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,17116,438,1.06 [0.94-1.21],0.3359952115993398
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,19251,2647,1.03 [0.98-1.09],0.2228360247762796
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,16950,272,0.86 [0.73-1.01],0.0742153330620572
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,16805,127,1.28 [1.02-1.62],0.0360928658254308
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16782,104,1.03 [0.79-1.34],0.8416762941592241
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,19398,88,1.01 [0.76-1.35],0.9307592994255788
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,13895,1729,1.04 [0.98-1.11],0.2267850901910508
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,12824,658,1.15 [1.03-1.27],0.0117364929537513
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19983,652,1.14 [1.02-1.26],0.0169154267469113
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,12230,64,0.95 [0.68-1.33],0.7816806568817124
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12434,268,0.92 [0.78-1.08],0.3030962781349093
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16905,227,0.93 [0.78-1.11],0.4236141601300871
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12581,415,1.08 [0.95-1.23],0.2543288240207167
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,16673,69,1.54 [1.12-2.11],0.0079523161545204
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,17175,571,1.07 [0.96-1.20],0.2404426663061225
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16861,257,1.11 [0.94-1.31],0.2287769176716481
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12554,388,1.07 [0.93-1.22],0.3482150746077583
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,16738,60,1.22 [0.86-1.72],0.261606079885517
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",16726,48,1.27 [0.87-1.86],0.2209253684996191
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,17881,69,1.06 [0.77-1.47],0.7146091822608793
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19702,1890,0.98 [0.92-1.04],0.4794620960449852
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,19145,1333,0.97 [0.90-1.05],0.4456365367960956
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19930,464,1.16 [1.02-1.31],0.0205387044483483
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14851,2685,1.05 [1.00-1.10],0.0761200289553978
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,12206,40,0.80 [0.52-1.23],0.3049203856193514
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,16766,88,1.05 [0.79-1.40],0.7516912939360906
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,12232,66,1.01 [0.72-1.41],0.9660844443600424
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),12283,117,1.07 [0.84-1.37],0.5902782209673443
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,18018,206,0.91 [0.75-1.10],0.3350527209087338
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,18226,414,0.97 [0.85-1.11],0.6295096966284837
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,20053,94,1.24 [0.95-1.64],0.1173341737779159
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",18275,1671,1.03 [0.97-1.10],0.3555010736694128
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16739,61,1.74 [1.25-2.42],0.0010894149714836
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),12298,132,1.02 [0.81-1.29],0.8475821311344549
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,17270,666,1.09 [0.99-1.21],0.0887141358746136
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,14047,1881,1.05 [0.99-1.12],0.1245425216578778
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,19418,108,1.10 [0.85-1.43],0.4505705265879771
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,20062,59,1.30 [0.92-1.83],0.1409237394242073
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16747,69,1.13 [0.82-1.56],0.4654719358606894
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17823,1145,1.11 [1.03-1.21],0.0071986629436801
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,16767,89,1.08 [0.81-1.44],0.6031273461270941
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,13949,1783,1.08 [1.01-1.15],0.0254787725430864
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,17915,103,0.91 [0.70-1.20],0.5184925820321014
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,16706,28,0.95 [0.57-1.60],0.8533375457822618
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,16771,167,0.96 [0.78-1.19],0.7376054263538478
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,17255,577,1.05 [0.94-1.18],0.3928136685185573
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19740,430,1.18 [1.04-1.35],0.0101438215241974
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,17155,551,1.03 [0.91-1.15],0.6584881879010878
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19941,459,1.16 [1.02-1.31],0.019428654276128
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,20048,58,1.71 [1.22-2.40],0.0017710146123409
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16817,139,1.00 [0.79-1.25],0.96711643226138
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,15658,744,1.11 [1.00-1.22],0.044179392396366
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,17219,541,1.09 [0.98-1.23],0.1254420418719879
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],16923,245,0.86 [0.72-1.03],0.093793127711384
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",12230,64,1.18 [0.84-1.64],0.3356824911998343
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14847,2681,1.10 [1.04-1.15],0.0005517595657179
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,12876,710,1.11 [1.01-1.23],0.0366809542056057
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19631,321,1.14 [0.98-1.33],0.0837467873782124
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",20023,64,1.02 [0.73-1.43],0.8923466971397119
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",17782,58,1.31 [0.92-1.85],0.1335894485441951
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,12226,60,1.28 [0.91-1.80],0.1569961419342806
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,16697,93,1.10 [0.83-1.46],0.4904429845695829
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,12637,471,1.18 [1.05-1.34],0.0076381392261434
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,16969,291,1.02 [0.87-1.19],0.8274596472404434
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16849,245,1.24 [1.05-1.47],0.0131717171064916
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,16826,222,1.07 [0.89-1.28],0.4776928787449365
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,14149,59,1.38 [0.98-1.94],0.0660895014222629
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",20052,62,1.57 [1.13-2.17],0.0072715856690709
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,17154,476,1.01 [0.89-1.14],0.8624961748575525
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],19397,87,1.40 [1.06-1.86],0.0176007952206942
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,18933,2255,1.05 [1.00-1.12],0.0693063436332746
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16806,128,0.98 [0.77-1.24],0.8465691953525216
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,17182,578,1.11 [0.99-1.24],0.070115219216362
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,18870,230,0.99 [0.83-1.19],0.922568437757634
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,16806,202,1.10 [0.91-1.33],0.3167199826288384
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,18267,1663,1.05 [0.98-1.12],0.1531886253945468
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17693,1089,1.05 [0.97-1.14],0.2257961788513127
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],16728,50,1.00 [0.68-1.46],0.9868327284210744
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19419,109,1.02 [0.79-1.32],0.8589034849576758
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16822,144,1.09 [0.88-1.37],0.4317446638797214
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,16760,82,0.93 [0.69-1.25],0.631557364118283
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),12228,62,1.23 [0.88-1.72],0.2322584369322066
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Acute renal failure,18927,1833,1.05 [0.99-1.12],0.1032301278525151
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),8084,21,1.67 [0.94-2.95],0.0803020517419119
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,10257,29,1.28 [0.78-2.09],0.3247640003378748
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19791,267,1.18 [1.00-1.39],0.0458552146423496
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19615,91,1.01 [0.76-1.34],0.955212324359462
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18848,1754,1.00 [0.94-1.07],0.9534361141429022
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19884,90,0.97 [0.73-1.29],0.8406633345091384
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19842,334,0.98 [0.84-1.13],0.7642941199312816
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Cystitis,16847,258,0.97 [0.82-1.15],0.7133940963547662
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Dialysis,17164,70,1.35 [0.98-1.86],0.0696798176404206
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8801,1825,1.03 [0.97-1.10],0.3789235549656983
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Disorders of breast,10339,111,1.16 [0.90-1.49],0.2568045598212203
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Endometriosis,8096,33,1.37 [0.87-2.17],0.1785068884175088
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8555,492,1.03 [0.91-1.16],0.6660715244035671
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16584,5310,1.02 [0.99-1.06],0.2093936841445154
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19862,68,1.08 [0.78-1.49],0.6525638016231037
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Hydrocele,7080,104,1.00 [0.76-1.31],0.9988551340196858
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,17125,278,1.05 [0.89-1.24],0.5515721459298875
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8533,1557,1.02 [0.95-1.09],0.5806192654288557
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10394,140,1.07 [0.85-1.34],0.5744134690607992
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),7081,105,0.78 [0.60-1.03],0.0788978957280776
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16661,72,1.13 [0.82-1.55],0.45486895531033
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,8949,886,0.98 [0.90-1.08],0.7395135597618872
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,7026,50,0.77 [0.52-1.14],0.1923827993986915
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,8096,33,0.75 [0.47-1.21],0.2423184807745884
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",20063,74,0.92 [0.67-1.26],0.6053113476703248
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",20057,74,0.84 [0.61-1.16],0.2895585268176741
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,19044,2455,1.00 [0.94-1.05],0.9213082608690992
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,17403,814,0.98 [0.89-1.08],0.6820029452490668
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,10274,46,0.92 [0.62-1.37],0.6971725792004292
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,20008,500,1.04 [0.92-1.17],0.53164948953427
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,7098,122,0.98 [0.76-1.26],0.8756925380150803
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,7111,135,1.03 [0.81-1.30],0.8027430384549976
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,7104,128,1.01 [0.79-1.29],0.9291388724718976
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,20039,70,1.03 [0.75-1.42],0.8579954635408963
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18501,1912,1.03 [0.96-1.09],0.419908041531094
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,10326,72,1.02 [0.74-1.40],0.8990678541943748
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,8127,64,1.26 [0.90-1.76],0.1741024654734638
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",8195,132,0.90 [0.71-1.14],0.3938980058303639
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,8113,50,0.91 [0.62-1.34],0.6385232424570108
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,8150,87,0.97 [0.73-1.30],0.8537825710322615
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,17174,327,1.06 [0.91-1.23],0.4441584193124824
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19670,162,1.12 [0.90-1.38],0.3090023762211822
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,8167,104,1.00 [0.77-1.30],0.9969771523367892
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,8085,22,0.73 [0.41-1.31],0.2893228034228194
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8250,187,1.01 [0.83-1.23],0.9508171944066748
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,8145,82,1.37 [1.03-1.83],0.0305043846394449
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8247,184,0.91 [0.75-1.12],0.3765937334510854
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19842,48,0.94 [0.64-1.40],0.7700275549865068
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",7106,130,0.88 [0.69-1.13],0.3148213781572632
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19857,3010,1.03 [0.98-1.08],0.2834593816366684
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",16923,76,1.08 [0.79-1.47],0.642760669508256
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,17233,139,1.02 [0.81-1.28],0.8805393908121719
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19557,33,1.10 [0.69-1.76],0.6898133810445259
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Urethral stricture,16818,229,1.03 [0.86-1.23],0.7259535282046808
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19868,344,1.13 [0.97-1.30],0.1076331117243876
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Uterine polyps,8097,34,1.04 [0.65-1.65],0.8729527783116946
